down arrow

Royalty Pharma Plc

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BMVP7Y09
  • NASDAQ: RPRX
USD
58.52
0.08 (0.14%)

Sep 22

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
674.14
630.58
622.00
609.29
578.66
568.25
594.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
674.14
630.58
622.00
609.29
578.66
568.25
594.00
Raw Material Cost
1.29
1.17
1.20
1.28
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
93.62
93.72
94.17
79.56
68.67
65.26
66.00
Selling and Distribution Expenses
441.88
158.32
158.80
118.22
272.30
110.70
68.00
Other Expenses
0.42
-5.39
-4.32
-2.91
23.18
-1.48
-6.50
Total Expenditure (Excl Depreciation)
541.02
199.28
211.00
170.00
572.80
161.21
69.00
Operating Profit (PBDIT) excl Other Income
133.1
431.3
411
439.3
5.8999999999999995
407
525
Other Income
7.71
25.79
2.90
21.28
9.48
14.67
78.45
Operating Profit (PBDIT)
142.12
659.44
392.10
449.71
219.28
548.85
439.45
Interest
93.62
93.72
94.17
79.56
68.67
65.26
66.00
Exceptional Items
34.28
-96.29
58.80
75.34
-59.97
-50.16
-39.45
Gross Profit (PBDT)
672.85
629.40
620.80
608.01
0.00
0.00
0.00
Depreciation
1.29
1.17
1.20
1.28
0.00
0.00
0.00
Profit Before Tax
81.49
468.26
356.00
444.21
90.64
433.43
334.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.88
294.69
214.00
288.22
30.18
238.35
208.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.88
294.69
214.00
288.22
30.18
238.35
208.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
63.60
173.57
142.00
155.99
60.46
195.08
126.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
81.49
468.26
356.00
444.21
90.64
433.43
334.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,832.74
6,888.55
6,476.90
6,414.35
6,347.91
6,688.65
6,946.58
Earnings per share (EPS)
0.04
0.67
0.5
0.67
0.07
0.55
0.47
Diluted Earnings per share
0.04
0.67
0.5
0.67
0.07
0.55
0.47
Operating Profit Margin (Excl OI)
19.75%
100.3%
62.38%
70.11%
36.26%
94.01%
60.77%
Gross Profit Margin
12.28%
74.44%
57.43%
73.12%
15.66%
76.28%
56.23%
PAT Margin
2.65%
46.73%
34.41%
47.3%
5.21%
41.94%
35.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 6.90% vs 1.38% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -82.60% vs 31.54% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -78.79% vs 62.82% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -0.11% vs -0.53% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Royalty Pharma Plc With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
674.14
3,762.20
-3,088.06
-82.08%
Other Operating Income
0.00
0.00
0.00
Total Operating income
674.14
3,762.20
-3,088.06
-82.08%
Raw Material Cost
1.29
2,185.10
-2,183.81
-99.94%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
93.62
119.80
-26.18
-21.85%
Selling and Distribution Expenses
441.88
855.00
-413.12
-48.32%
Other Expenses
0.42
12.54
-12.12
-96.65%
Total Expenditure (Excl Depreciation)
541.02
3,285.30
-2,744.28
-83.53%
Operating Profit (PBDIT) excl Other Income
133.12
476.90
-343.78
-72.09%
Other Income
7.71
64.80
-57.09
-88.10%
Operating Profit (PBDIT)
142.12
1,214.00
-1,071.88
-88.29%
Interest
93.62
119.80
-26.18
-21.85%
Exceptional Items
34.28
-485.90
520.18
107.05%
Gross Profit (PBDT)
672.85
1,577.10
-904.25
-57.34%
Depreciation
1.29
672.30
-671.01
-99.81%
Profit Before Tax
81.49
-64.00
145.49
227.33%
Tax
0.00
54.80
-54.80
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
17.88
-118.80
136.68
115.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.88
-118.80
136.68
115.05%
Share in Profit of Associates
0
0
0.00
Minority Interest
63.60
0.00
63.60
Other related items
0.00
0.00
0.00
Consolidated Net Profit
81.49
-118.80
200.29
168.59%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,832.74
14,260.40
-7,427.66
-52.09%
Earnings per share (EPS)
0.04
-0.10
0.14
140.00%
Diluted Earnings per share
0.04
-0.10
0.14
140.00%
Operating Profit Margin (Excl OI)
19.75%
12.68%
0.00
7.07%
Gross Profit Margin
12.28%
16.17%
0.00
-3.89%
PAT Margin
2.65%
-3.16%
0.00
5.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 67.41 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 6.90% vs 1.38% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 16.49% vs 7.71% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.15 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -82.60% vs 31.54% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -10.04% vs -53.40% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.44 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -78.79% vs 62.82% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -35.94% vs -22.18% in Jun 2025

Quarterly - Interest
Interest 9.36 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -0.11% vs -0.53% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 36.24% vs 40.20% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.75%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Footer loading